Table 3.

Validation statistics for AGB estimation grouped by genotype, with 3 or more estimations per experimental site (extreme values per experimental test site are highlighted in boldface).

Location	Genotype	No. of plots	RMSE	RRMSE	ASE	MPSE
1 (ACRE)	4J105-3-4	4	19.75	13.63	-4.34	0.70
	5M20-2-5-2	5	27.19	16.38	1.32	0.65
	CL0J095-4-6	5	15.66	10.32	7.84	2.40
	CL0J173-6-8	4	28.16	16.25	4.50	0.43
	LD02-4485	4	34.05	24.13	14.04	7.12
	LD02-9050	3	19.18	11.34	-2.99	2.15
	LG00-3372	6	25.12	18.22	8.29	4.38
	LG04-6000	5	30.63	18.94	1.10	11.00
	LG05-4464	4	16.01	10.19	4.63	1.61
	LG05-4832	4	23.69	14.28	-0.66	1.46
	LG94-1906	3	49.67	27.83	-7.41	10.31
	Magellan	8	17.13	11.38	6.33	0.26
	PI398881	5	23.23	13.84	-6.24	3.31
	PI437169B	3	6.70	3.98	0.55	1.18
	Prohio	3	17.13	11.10	8.56	0.42
	Skylla	4	35.06	20.49	-4.42	6.50
	TN05-3027	5	11.64	7.33	-2.91	0.52
2 (Romney)	4J105-3-4	3	25.32	19.08	5.80	0.77
	5M20-2-5-2	3	10.70	8.10	-3.13	3.86
	CL0J095-4-6	4	20.26	17.00	10.46	6.16
	CL0J173-6-8	4	7.95	7.33	2.34	1.16
	LD02-4485	3	18.24	13.07	-8.69	4.31
	LD02-9050	3	21.54	15.98	6.82	10.00
	LG00-3372	7	14.15	12.89	7.25	2.60
	LG04-6000	5	11.42	9.82	1.46	3.42
	LG05-4464	6	19.82	13.66	-4.59	2.13
	LG05-4832	4	17.87	12.41	-8.19	0.04
	LG94-1906	4	19.53	19.64	14.81	1.98
	Magellan	6	14.87	12.23	-4.56	3.71
	PI437169B	3	7.08	5.16	-5.11	1.58
	Prohio	3	7.71	5.46	-5.08	0.72
	Skylla	4	19.52	15.92	1.27	3.11
	TN05-3027	4	23.32	19.58	-0.34	6.55